Wayne H Winegarden

Drug Prices

NEW STUDY: 340B Providers Reap Big Profits, Should Be Reformed to Ensure At-Risk Patients Receive Affordable Care

SACRAMENTO – The broken 340B program, designed to provide affordable care for at-risk patients, creates massive profits for providers without necessarily improving patient health outcomes and should be reformed, finds a new issue brief released today by the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute. …

Featured

NEW BRIEF: Establishing An Efficient Health Insurance Market

DOWNLOAD THE BRIEF   Cultivating an efficient health insurance market requires reforms that empower patients over payers, which can be achieved by: Making health expenditures and health insurance expenditures tax deductible; Broadening the availability and usability of tax-free saving accounts to help patients cover the deductibles and out of pocket …

Featured

NEW BRIEF: Broken System Imposes Higher Out-of-Pocket Costs on Patients, Puts Interests of Government and Insurers First

America’s broken third-party healthcare payment system prioritizes government and insurance companies as the largest payers, leaving patients with higher out-of-pocket costs, greater exposure to healthcare financial risk, and reduced access to care – finds the latest paper in the Coverage Denied series released today by the Center for Medical Economics …

Climate Change

States and Municipal Lawsuits Undermine Innovative Climate Solutions

Cities and states are attempting to set the nation’s energy policies through the judicial system rather than the appropriate legislative process. Dozens of states and localities including New York City, Baltimore, and various California cities have filed suits claiming that oil and gas companies should be held responsible for the …

Commentary

Drug Pricing Reforms Should Expand Choice, Not Government Control

As President Biden‘s recent State of the Union address made clear, drug pricing will remain a top policy issue for the foreseeable future. The president is correct that something must be done, but his proposals are wrongheaded and will only make things worse. Instead of focusing on government price controls, Congress …

Business & Economics

NEW STUDY: Rejecting Push to Restrict Gig Entrepreneurship Key to Driving Innovation, Economic Growth, Higher Incomes

Amid a renewed push in Congress and states to enact new gig economy restrictions following California’s controversial AB 5, a new study released today by the nonpartisan Pacific Research Institute finds that enacting these harmful laws would hinder innovation and restrict people’s ability to become entrepreneurs and provide for their …

Business & Economics

The Empty Case for Stakeholder Capitalism and ESG Investing

Instead of promoting responsible behavior, these practices undermine the principles of good corporate governance. Larry Fink, the chairman and CEO of BlackRock, is selling the idea that the world economy must embrace stakeholder capitalism and environmental, social, and governance (ESG) investing. Don’t worry, though, he wants you to know that stakeholder …

Drug Prices

NEW STUDY: Creating Two-Part Drug Pricing System Would Ensure Prices More Accurately Reflect How Patients

Establishing a two-part drug pricing system quantifying separate values for a drug’s innovation and production would create an efficient market and a more accurate reflection of how patients value a drug compared to those produced by centralized organizations, argues a new report released today by the Center for Medical Economics …

Business & Economics

Controlling Inflation Requires A Better Policy Mix, Not Business Scapegoating

Thanks to errant fiscal and monetary policies, consumer prices continued their relentless climb in December. Just as predictably, politicians seem to be more interested in “rounding up the usual suspects” rather than implementing the right policy mix that would rein in inflation. Political fecklessness in face of rising prices is …

Featured

The Fundamental Flaws of the Third-Party Payer System

Part 1 of the Coverage Denied series documented how distortions in the U.S. healthcare system turned the important financial risk management service of health insurance into a barrier to care and an important driver of health care inflation. The insurance industry’s adverse impact on costs is ironic given its current …

Drug Prices

NEW STUDY: 340B Providers Reap Big Profits, Should Be Reformed to Ensure At-Risk Patients Receive Affordable Care

SACRAMENTO – The broken 340B program, designed to provide affordable care for at-risk patients, creates massive profits for providers without necessarily improving patient health outcomes and should be reformed, finds a new issue brief released today by the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute. …

Featured

NEW BRIEF: Establishing An Efficient Health Insurance Market

DOWNLOAD THE BRIEF   Cultivating an efficient health insurance market requires reforms that empower patients over payers, which can be achieved by: Making health expenditures and health insurance expenditures tax deductible; Broadening the availability and usability of tax-free saving accounts to help patients cover the deductibles and out of pocket …

Featured

NEW BRIEF: Broken System Imposes Higher Out-of-Pocket Costs on Patients, Puts Interests of Government and Insurers First

America’s broken third-party healthcare payment system prioritizes government and insurance companies as the largest payers, leaving patients with higher out-of-pocket costs, greater exposure to healthcare financial risk, and reduced access to care – finds the latest paper in the Coverage Denied series released today by the Center for Medical Economics …

Climate Change

States and Municipal Lawsuits Undermine Innovative Climate Solutions

Cities and states are attempting to set the nation’s energy policies through the judicial system rather than the appropriate legislative process. Dozens of states and localities including New York City, Baltimore, and various California cities have filed suits claiming that oil and gas companies should be held responsible for the …

Commentary

Drug Pricing Reforms Should Expand Choice, Not Government Control

As President Biden‘s recent State of the Union address made clear, drug pricing will remain a top policy issue for the foreseeable future. The president is correct that something must be done, but his proposals are wrongheaded and will only make things worse. Instead of focusing on government price controls, Congress …

Business & Economics

NEW STUDY: Rejecting Push to Restrict Gig Entrepreneurship Key to Driving Innovation, Economic Growth, Higher Incomes

Amid a renewed push in Congress and states to enact new gig economy restrictions following California’s controversial AB 5, a new study released today by the nonpartisan Pacific Research Institute finds that enacting these harmful laws would hinder innovation and restrict people’s ability to become entrepreneurs and provide for their …

Business & Economics

The Empty Case for Stakeholder Capitalism and ESG Investing

Instead of promoting responsible behavior, these practices undermine the principles of good corporate governance. Larry Fink, the chairman and CEO of BlackRock, is selling the idea that the world economy must embrace stakeholder capitalism and environmental, social, and governance (ESG) investing. Don’t worry, though, he wants you to know that stakeholder …

Drug Prices

NEW STUDY: Creating Two-Part Drug Pricing System Would Ensure Prices More Accurately Reflect How Patients

Establishing a two-part drug pricing system quantifying separate values for a drug’s innovation and production would create an efficient market and a more accurate reflection of how patients value a drug compared to those produced by centralized organizations, argues a new report released today by the Center for Medical Economics …

Business & Economics

Controlling Inflation Requires A Better Policy Mix, Not Business Scapegoating

Thanks to errant fiscal and monetary policies, consumer prices continued their relentless climb in December. Just as predictably, politicians seem to be more interested in “rounding up the usual suspects” rather than implementing the right policy mix that would rein in inflation. Political fecklessness in face of rising prices is …

Featured

The Fundamental Flaws of the Third-Party Payer System

Part 1 of the Coverage Denied series documented how distortions in the U.S. healthcare system turned the important financial risk management service of health insurance into a barrier to care and an important driver of health care inflation. The insurance industry’s adverse impact on costs is ironic given its current …

Scroll to Top